Gapping down
In reaction to disappointing earnings/guidance:
- TGT -7.1%, PNC -1%, UNH -0.5%, DIOD -0.4% (guides Q4 revenue in-line), GS -0.3%
Other news:
- NKTR -15.8% (FDA Advisory Committee vote on oxycodegol gel indicated data from one pivotal study is not enough to support use)
Analyst comments:
- FSLR -4.8% (downgraded to Underweight from Overweight at Barclays)
- BYND -3.2% (downgraded to Mkt Perform from Outperform at Bernstein)
- CDLX -2.5% (downgraded to Mkt Perform from Outperform at Raymond James)